Search For "dr randeep guleria"
Vice President Naidu presents Lal Bahadur Shastri National Award f
Updated : 4 days, 4 hours ago IST
New Delhi [India], October 11 (ANI): Vice President M Venkaiah Naidu presented Lal Bahadur Shastri National Award for Excellence to Director of the All India Institute of Medical Sciences (AIIMS), Dr Randeep Guleria on Monday.
Read More
Vaccination of children only way to get rid of COVID pandemic: AII
Updated : 1 week, 6 days ago IST
New Delhi [India], October 2 (ANI): Children between 12 to 18 years of age will be vaccinated against COVID-19 very soon, said Dr Randeep Guleria, Director of All Indian Institute of Medical Sciences (AIIMS), Delhi.
Read More
COVID-19: AIIMS Delhi Director appeals people to be careful during
Updated : 2 weeks ago IST
New Delhi [India], October 1 (ANI): With the festive season just around the corner, All India Institute of Medical Studies (AIIMS) Director Dr Randeep Guleria on Friday appealed to people to be careful and follow COVID-19 protocols during this festive season.
Read More
Mauritius ex-PM Navinchandra Ramgoolam discharged from AIIMS
Updated : 3 weeks, 4 days ago IST
New Delhi [India], September 20 (ANI): Former Mauritius Prime Minister Navinchandra Ramgoolam has been discharged from All India Institute of Medical Sciences (AIIMS) in Delhi on Monday.
Read More
Focus should be on vaccinating everybody, booster doses can wait:
Updated : 1 month, 3 weeks ago IST
New Delhi [India], August 25 (ANI): India should now focus on vaccinating as many people as possible to curb the spread of Covid and the idea of booster doses can wait, for now, said Randeep Guleria, Chief, All India Institute Of Medical Sciences (AIIMS).
Read More
Second wave not over, third wave depends on people's behaviour: Dr
Updated : 2 months ago IST
New Delhi [India], August 13 (ANI): The second wave of Coronavirus pandemic is not yet over and the third wave depends on the Covid-19 appropriate behaviour by the people, said Randeep Guleria, the Director of Delhi AIIMS, on Friday.
Read More
COVAXIN trial results on children likely by September: AIIMS chief
Updated : 2 months, 3 weeks ago IST
New Delhi [India], July 24 (ANI): Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria informed.
Read More
May need COVID-19 vaccine booster shots for emerging variants: AII
Updated : 2 months, 3 weeks ago IST
New Delhi [India], July 23 (ANI): With various mutations of the SARS-CoV-2 emerging in the near future, there might be a need for the country to adopt a booster dose with second-generation COVID-19 vaccines, said All India Institute of Medical Sciences (AIIMS) chief Dr Randeep Guleria. Read More
The virus will not mutate "dramatically" in the forthcoming months
Updated : 2 months, 3 weeks ago IST
New Delhi [India], July 23 (ANI): Director of All India Institute of Medical Sciences in Delhi, Dr Randeep Guleria said that the virus will not mutate "dramatically" in the forthcoming months.
Read More
Graded reopening of schools is advisable: AIIMS Director Dr Guleri
Updated : 2 months, 3 weeks ago IST
New Delhi [India], July 23 (ANI): All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria on Friday said the schools in the areas where the Covid positivity rate is low can be reopened.
Read More
Third-wave may not come if COVID norms are followed, vaccination d
Updated : 3 months, 2 weeks ago IST
New Delhi [India], July 1 (ANI): If people are careful and India is able to vaccinate a large number of population, then the third wave of COVID-19 pandemic may not even come, said All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria on Thursday.
Read More
Not much data on Delta plus variant to suggest it's more infectiou
Updated : 3 months, 2 weeks ago IST
New Delhi [India], July 1 (ANI): The Director of All India Institute of Medical Sciences (AIIMS), Delhi, Dr Randeep Guleria on Thursday said that there is not much data available on the Delta plus variant to suggest that it is more infective or has a higher rate of mortality.
Read More